MedTrace Logo

The Effect of Human Albumin on Coagulation Competence and Hemorrhage

NCT02270723 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2014-10-21

No results posted yet for this study

Summary

In a randomized clinical trial, the purpose is to investigate if perioperative coagulation and hemorrhage is influenced by colloid or crystalloid.

Conditions

  • Hemorrhage; Complicating Delivery, Coagulation Defect

Interventions

DRUG

5% Human Albumin " Behring"

Intravenous infusion of 5% Human Albumin during major surgery

DRUG

Lactated Ringer

Intravenous infusion of Lactated Ringer during major surgery

Sponsors & Collaborators

  • Kirsten Cleemann Rasmussen

    lead OTHER

Principal Investigators

  • Niels H Secher, MD PHD Prof · Rigshospitalet, University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-08-31
Completion
2015-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02270723 on ClinicalTrials.gov